Organogenesis Holdings Inc. ORGO Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s additional paid-in capital?
- Organogenesis Holdings Inc. (ORGO) reported additional paid-in capital of $300.78M in Q1 2026.
- How has Organogenesis Holdings Inc.'s additional paid-in capital changed year-over-year?
- Organogenesis Holdings Inc.'s additional paid-in capital decreased by 0.4% year-over-year, from $301.84M to $300.78M.
- What is the long-term trend for Organogenesis Holdings Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s additional paid-in capital has grown at a 0.4% compound annual growth rate (CAGR), from $296.83M to $303.19M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.